SCHEMBL2764061

SCHEMBL2764061

NC1(N)N=CN=C(c2ccccc2)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 2/20 0.37
NISCH Q9Y2I1 4/20 0.33
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
CYP1A2 P05177 1/20 0.32
GAA P10253 3/20 0.32
NPC1 O15118 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SCN4A P35499 1/20 0.31
MAPT P10636 1/20 0.31
AKT2 P31751 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4212721 0.73 NPY5R (0.41) NPY5RNISCHKMT2AMEN1ALDH1A1
SCHEMBL20593963 0.66 ALDH1A1 (0.38) NPY5RKDM4EALDH1A1LMNAGAA
SCHEMBL1047773 0.59
SCHEMBL21679634 0.57 RAB9A (0.46) NPY5RNISCHKMT2AMEN1ALDH1A1
SCHEMBL11154267 0.57 NISCH (0.44) NPY5RNISCHKMT2AMEN1ALDH1A1
Biphenyl SCHEMBL2574161 0.53 ALDH1A1 (0.82) ALDH1A1CYP1A2NPC1RAB9AHSD17B10
SCHEMBL444478 0.52 ALDH1A1 (0.53) KMT2AMEN1KDM4EALDH1A1LMNA
Biphenyl SCHEMBL2548048 0.52 ALDH1A1 (1.00) ALDH1A1LMNACYP1A2NPC1RAB9A
Biphenyl SCHEMBL4002609 0.52 ALDH1A1 (1.00) ALDH1A1LMNACYP1A2NPC1RAB9A
Biphenyl SCHEMBL164 0.52 ALDH1A1 (1.00) ALDH1A1LMNACYP1A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423371-B1 TRIAZINE DERIVATIVES AND THEIR USE AS SUNSCREENS BASF SE (DE) 2010-10-20 EP disclosed
US-7038046-B2 Triazine derivatives and their use as sunscreens CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-05-02 US disclosed
US-20040242579-A1 Triazine derivatives and their use as sunscreens CIBA SPECIALTY CHEMICALS CORP. 2004-12-02 US disclosed
EP-1423371-A1 TRIAZINE DERIVATIVES AND THEIR USE AS SUNSCREENS Ciba SC Holding AG (CH) 2004-06-02 EP disclosed
WO-2003016289-A1 TRIAZINE DERIVATIVES AND THEIR USE AS SUNSCREENS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242579-A1 Triazine derivatives and their use as sunscreens CBR1, CBR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 NPY5R 349/4885NISCH 312/4885KMT2A 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.